Chronos Archive seal

Review checklist: Benjamin Franklin (HR-EN004)

All records · Back to the record · Dossier (sources.md) · Terminology · Report a problem · Comments

Everything a reviewer needs to judge, gathered from the record. Release status: draft.

Review status

ReviewStatusReviewerDateNotes
schema validationnot_startedRun scripts/build.ps1 -Conformance.
clinical reviewnot_startedAwaiting clinician review; check allopurinol titration in stage 3a CKD, colchicine with atorvastatin, potassium citrate with losartan, and the two titration and potassium-check deviations recorded.
provenance reviewnot_startedGutenberg editions of his letters, works, and autobiography, two PubMed abstracts, and an American Battlefield Trust biography logged; Founders Online could not be fetched (bot challenge). Lead poisoning is graded R, possible.
safe messaging reviewnot_startedNo behavioral-health content; laudanum use in his last year is recorded only as historical fact; death recorded without graphic detail.

Judgment calls (dossier editorial resolutions)

  1. Birth date. The preferred date is the Gregorian January 17, 1706. The autobiography's note gives January 6, 1706, Old Style, the same day in the Julian calendar; it is recorded as a superseded alternative. The synthetic date of birth keeps January 17.
  2. Index age. The episode presents him at 76, the age at which the 1806 biographical account places the first symptoms of his stone (about 1781) and soon after the severe gout he described in March 1781. The synthetic date of birth is January 17, 1950, so the whole-year shift is 244 years. The index visit is March 2, 2026 (true frame March 2, 1782); the chronic-care visits follow on March 30, May 18, and September 14, 2026 (true frame March 30, May 18, and September 14, 1782); the surgery is April 20, 2026 (true frame April 20, 1782); the sick visit is July 6, 2026 (true frame July 6, 1782) and the annual wellness visit October 19, 2026 (true frame October 19, 1782). He lived to 84, so all fall within his lifetime. The visit type is `annual_wellness_subsequent` because he is 65 or older.
  3. Gout and stone. Both are documented in his own letters (D). The composition and cause of his historical stone are not documented. The synthetic episode makes it a uric acid bladder stone behind benign prostatic hyperplasia, a common modern combination in older men with gout; the prostate diagnosis is synthetic and does not claim that he had it. His physician's account says only “the stone”; it is recorded as a bladder stone because the roster, the 2008 review, and his own descriptions of pain with jolting travel point that way, and no kidney location is asserted.
  4. Lead. His exposure to heated type metal in 1724 and the pain in the bones of his hand are documented in his own letter (D). Lead poisoning as a contributor to his gout is a retrospective interpretation (R, possible) and is not on the problem list. The modern episode checks one synthetic blood lead level (3.1 µg/dL, below the adult reference value) to teach that blood lead reflects recent rather than lifetime exposure.
  5. Kidney disease and hypertension. No measure of his kidney function or blood pressure exists. The stage 3a chronic kidney disease and the hypertension are synthetic, added because they change gout care (allopurinol start dose, avoiding NSAIDs, replacing a thiazide with losartan). Obesity is suggested by the 2023 review (R, possible) and is represented only by the synthetic BMI.
  6. Family history. The autobiography gives his parents' ages at death and his son's death from smallpox. Causes for his parents are not recorded, and nothing is attributed to any relative beyond what the source states.
  7. Not used. Founders Online (National Archives) could not be fetched because of a bot challenge, so the letters are cited from the public-domain Gutenberg editions; a 1786 lead letter transcription on another site was not used. The roster's psoriasis, pleurisy as an anchor condition, skin conditions, and presbyopia were not pursued; the past pleurisies are recorded as history only. A secondary statement that gout kept him from most sessions as a Pennsylvania delegate was seen on the birth-date source but is not used. Laudanum in his last year is recorded as history and does not enter the synthetic medication list.
  8. Sick and wellness visits. The sick visit is a crystal-proven gout flare of the left knee during allopurinol titration, chosen because flares are common in the first months of urate lowering and because it teaches flare treatment with CKD (a short prednisone course, no NSAIDs, allopurinol continued) and aspiration of a new large joint. It does not echo a dated historical attack. The wellness visit adds a synthetic positive AUDIT-C (4) with brief counseling, which is not an alcohol use disorder diagnosis, and its advance care planning names no real person.
  9. Focused visits. The three chronic-care follow-ups (four weeks, eleven weeks, and about six months) are documented as focused visits on the ACR gout and AUA/EAU stone guidelines and the CMID hypertension, chronic kidney disease, and BPH monographs. Four deviations are recorded as `deferred`, each with its outcome and corrective action, and no result was invented: the urate check two to five weeks after the first allopurinol increase (drawn at seven weeks, because surgery intervened); the urate check after the second increase (first drawn at the flare visit at seven weeks); the potassium check two to four weeks after starting potassium citrate with losartan (first drawn at seven weeks); and the three-month post-procedural urologic check (no separate visit).
  10. Consultation. The urology referral and consultation are synthetic. The cystoscopy, uroflowmetry, and residual on the consultation day are the record's procedures and results. Its recommendations match what followed: combined cystolitholapaxy and transurethral resection, tamsulosin until surgery, no PSA, post-operative urinalysis and 24-hour urine, potassium citrate with potassium monitoring, and IPSS and residual checks after surgery.
  11. Franklin died in 1790, so the recent-death review rule does not apply. Ordinary clinical, provenance, and safe-messaging reviews remain required.

Protocol deviations

Checks the monitoring protocol called for that the schedule did not perform. Each is recorded with its outcome and corrective action, never filled with an invented result.

VisitMeasureIntervalWhat happened
2026-05-18
Progress note 03 (C-CDA)
Serum urate 2 to 5 weeks after raising allopurinol to 200 mgOnce after each dose changeNot drawn in the window, a deviation from the protocol; the surgery fell in that period and the check was not rebooked. It is seven weeks today. No harm: no flare, and the dose is raised today. Corrective action: a standing urate order every four weeks until target
2026-09-14
Progress note 05 (C-CDA)
Serum urate 2 to 5 weeks after raising allopurinol to 300 mgOnce after each dose changeNot drawn in the window, a deviation from the protocol; the first value came at the July flare visit at seven weeks (5.9 mg/dL, unreliable during a flare). No change in management resulted, and today's 5.4 confirms the target. Corrective action: the standing order now prints at each visit
2026-09-14
Progress note 05 (C-CDA)
Potassium 2 to 4 weeks after starting potassium citrate with losartan in chronic kidney diseaseOnce after starting; then periodicallyNot drawn in the window, a deviation from the protocol; first checked at the July sick visit at seven weeks (4.7 mmol/L). No harm: potassium 4.6 today. Corrective action: potassium is added to the standing order whenever a potassium-raising drug is started
2026-09-14
Progress note 05 (C-CDA)
Three-month post-procedural urologic checkAbout 3 months after the procedureNo separate visit was held at three months, a deviation from the follow-up schedule; urinary symptoms were reviewed and negative at the July sick visit. No harm: IPSS and residual are normal today

Orders and referrals without results in the record

None.

Evidence to check

Retrospective claims (R)

ClaimStatementCertainty
CLM-0004The same review argues that several factors that raise uric acid converged in him, including sex, genetics, diet, drinking, advanced age, psoriasis, and possible lead poisoning from lead exposure.possible
CLM-0016A 2023 review describes him as overweight and as probably having had consequences of the metabolic syndrome, including gout.possible

Sensitive claims

None.

Diagnoses not confirmed

None.

Notes to read

Every note in the record, with its type. All clinical content is synthetic.

Abnormal results

DateResultValueFlag
2026-03-02Serum urate9.1 mg/dL (high)High
2026-03-02Creatinine1.36 mg/dL (high)High
2026-03-02eGFR54 mL/min/1.73 m² (low)Low
2026-03-02LDL cholesterol128 mg/dL (high)High
2026-03-02Urine red cells12 /[HPF] (high)High
2026-03-30Serum urate7.6 mg/dL (high)High
2026-03-30eGFR55 mL/min/1.73 m² (low)Low
2026-03-30Post-void residual volume by bladder ultrasound160 mL (high)High
2026-03-30Maximum urine flow rate (Qmax)8.5 mL/s (low)Low
2026-05-18eGFR56 mL/min/1.73 m² (low)Low
2026-05-1824-hour urine volume1.45 L/(24.h) (low)Low
2026-05-1824-hour urine uric acid840 mg/(24.h) (high)High
2026-09-14eGFR56 mL/min/1.73 m² (low)Low
2026-07-06eGFR55 mL/min/1.73 m² (low)Low
2026-07-06Glucose104 mg/dL (high)High